My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
NDF Research
Latest news and analysis on NDF Research
September 07, 2016 19:16
Botanix Pharmaceuticals (ASX: BOT) - Management that have done it before
Stuart Roberts
Pitt Street Research and NDF Research
September 07, 2016 19:16
September 06, 2016 06:41
Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback
Stuart Roberts
Pitt Street Research and NDF Research
September 06, 2016 06:41
September 05, 2016 11:14
Cynata (ASX: CYP) - Australian stem-cell know-how gets picked up in Japan
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 11:14
Advertisement
September 05, 2016 10:34
Sirtex (ASX: SRX) - A therapy going mainstream
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 10:34
September 02, 2016 07:20
AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors
Stuart Roberts
Pitt Street Research and NDF Research
September 02, 2016 07:20
September 01, 2016 07:22
Starpharma (ASX:SPL) - It's big business putting new life into old drugs
Stuart Roberts
Pitt Street Research and NDF Research
September 01, 2016 07:22
August 26, 2016 16:10
The Coming Boom in Life Sciences in Australia
Stuart Roberts
Pitt Street Research and NDF Research
August 26, 2016 16:10
41-47 of 47
1
2
3
4
5
most
popular
Equities
Question everything
Martin Conlon,
Schroders
Buy Hold Sell
Buy Hold Sell: 6 ASX stocks built to handle tough
conditions
Patrick Poke,
Livewire Markets
Buy Hold Sell
Buy Hold Sell: 5 ASX fallen angels prime for a
comeback
Anna Dadic,
Livewire Markets
Equities
The Anthropic IPO is on! We looked under the hood, here are the Red Flags...
Dr David Allen,
Plato Investment Management
view all
Advertisement
